Trade Summary

6 days ago, Norwalk Leslie V, serving as Dir at NEUROCRINE BIOSCIENCES INC (NBIX), sold 1,250 shares at $168.06 per share, for a total transaction value of $210,071.63. Following this transaction, Norwalk Leslie V now holds 2,838 shares of NBIX.

This sale represents a 30.58% decrease in Norwalk Leslie V's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 8, 2026 at 6:07 PM ET, 4 days after the trade was made.

NEUROCRINE BIOSCIENCES INC operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.